Bookmark and Share

Participate in a Research Study

Current trial titles

11-GYN-098-MCC: A Non-randomized Neoadjuvant Platinum-based Chemotherapy in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Trial Protocol (IRB #11-0903-F3R)

11-GYN-130: Treatment of Endometrial Cancer Utilizing Pathology Intraoperative Consultation to Determine Extent of Surgical Staging (IRB #11-0901-F6A)

GOG-0238: A Randomized Trial Of Pelvic Irradiation With Or Without Concurrent Weekly Cisplatin In Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus (IRB #08-0769-F1V)

GOG-0258: A Randomized Phase III Trial Of Cisplatin And Tumor Volume Directed Irradiation Followed By Carboplatin And Paclitaxel Vs. Carboplatin And Paclitaxel For Optimally Debulked, Advanced Endometrial Carcinoma (IRB #09-0902-F1V)

GOG-0260: A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer (IRB #11-0350-F6A)

GOG-0261: A Randomized Phase III Trial of Paclitaxel plus Carboplatin versus Ifosfamide plus Paclitaxel in Chemotherapy- Naive Patients with Newly Diagnosed Stage I-IV Persistent or Recurrent Carcinoma (Mixed Mesodermal Tumors) of the Uterus (IRB #10-0067-F6A)

GOG-0263: Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA, Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphdenectomy (IRB #11-0556-F6A)

GOG-3001 (Trinova-3, Amgen 20101129/ENGOT-ov2): A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers (IRB #13-0274-F1V)

88-GYN-13: Transvaginal Ultrasonography As a Screening Method for Ovarian Cancer

Complete trial information


Protocol No. 

11-GYN-098-MCC

Title 

11-GYN-098-MCC: A Non-randomized Neoadjuvant Platinum-based Chemotherapy in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Trial Protocol (IRB #11-0903-F3R)

Pl Name 

Miller, Rachel, W

Phase 

Phase II

Protocol Type 

Therapeutic intervention

Summary 4 Type 

Agent/Device

Age Group 

Adults

Sponsor Type 

Institutional


Protocol No. 

11-GYN-130

Title 

11-GYN-130: Treatment of Endometrial Cancer Utilizing Pathology Intraoperative Consultation to Determine Extent of Surgical Staging (IRB #11-0901-F6A)

Pl Name 

Ueland, Frederick

Phase 

Phase II

Protocol Type 

Therapeutic intervention

Summary 4 Type 

Agent/Device

Age Group 

Adults

Sponsor Type 

Institutional


Protocol No. 

GOG-0238

Title 

GOG-0238: A Randomized Trial Of Pelvic Irradiation With Or Without Concurrent Weekly Cisplatin In Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus (IRB #08-0769-F1V

Pl Name 

Ueland, Frederick

Phase 

Phase II

Protocol Type 

Therapeutic intervention

Summary 4 Type 

Agent/Device

Age Group 

Adults

Sponsor Type 

National group


Protocol No. 

GOG-0258

Title 

GOG-0258: A Randomized Phase III Trial Of Cisplatin And Tumor Volume Directed Irradiation Followed By Carboplatin And Paclitaxel Vs. Carboplatin And Paclitaxel For Optimally Debulked, Advanced Endometrial Carcinoma (IRB #09-0902-F1V)

Pl Name 

Ueland, Frederick

Phase 

Phase III

Protocol Type 

Therapeutic intervention

Summary 4 Type 

Agent/Device

Age Group 

Adults

Sponsor Type 

National group


Protocol No. 

GOG-0260

Title 

GOG-0260: A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer (IRB #11-0350-F6A)

Pl Name 

Ueland, Frederick

Phase 

Phase II

Protocol Type 

Therapeutic intervention

Summary 4 Type 

Agent/Device

Age Group 

Adults

Sponsor Type 

National group


Protocol No. 

GOG-0261

Title 

GOG-0261: A Randomized Phase III Trial of Paclitaxel plus Carboplatin versus Ifosfamide plus Paclitaxel in Chemotherapy- Naive Patients with Newly Diagnosed Stage I-IV Persistent or Recurrent Carcinoma (Mixed Mesodermal Tumors) of the Uterus (IRB #10-0067-F6A)

Pl Name 

Ueland, Frederick

Phase 

Phase III

Protocol Type 

Therapeutic intervention

Summary 4 Type 

Agent/Device

Age Group 

Adults

Sponsor Type 

Institutional


Protocol No. 

GOG-0263

Title 

GOG-0263: Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA, Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphdenectomy (IRB #11-0556-F6A)

Pl Name 

Ueland, Frederick

Phase 

Phase III

Protocol Type 

Therapeutic intervention

Summary 4 Type 

Agent/Device

Age Group 

Adults

Sponsor Type 

National group


Protocol No. 

GOG-3001/AMGEN

Title 

GOG-3001 (Trinova-3, Amgen 20101129/ENGOT-ov2): A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers (IRB #13-0274-F1V)

Pl Name 

Ueland, Frederick

Phase 

Phase III

Protocol Type 

Therapeutic intervention

Summary 4 Type 

Agent/Device

Age Group 

Adults

Sponsor Type 

National group


Protocol No. 

88-GYN-13

Title 

Transvaginal Ultrasonography As a Screening Method for Ovarian Cancer

Pl Name 

van Nagell Jr., John

Phase 

NA

Protocol Type 

Screening, Early Detection or Diagnosis

Summary 4 Type 

Other interventions

Age Group 

Adults

Sponsor Type 

Institutional

Page last updated: 3/13/2014 3:26:49 PM